• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Suez Canal University Medical Journal
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 28 (2025)
Volume Volume 27 (2024)
Issue Issue 12
Issue Issue 11
Issue Issue 10
Issue Issue 9
Issue Issue 8
Issue Issue 7
Issue Issue 6
Issue Issue 5
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 26 (2023)
Volume Volume 25 (2022)
Volume Volume 24 (2021)
Volume Volume 23 (2020)
Volume Volume 22 (2019)
Volume Volume 21 (2018)
Volume Volume 20 (2017)
Volume Volume 19 (2016)
Volume Volume 18 (2015)
Volume Volume 17 (2014)
Volume Volume 16 (2013)
Volume Volume 15 (2012)
Volume Volume 14 (2011)
Volume Volume 13 (2010)
Eiada, M., Attia, F., Ismail, N., Mohamed, D. (2024). Serum Level of P19 Subunit of Human Interleukin 23 in Psoriatic Patients Before & After Phototherapy of Ultra-Violet B (UVB) in Dermatology Outpatient Clinic Suez Canal University. Suez Canal University Medical Journal, 27(5), 0-0. doi: 10.21608/scumj.2024.399067
Moustafa MK. Eiada; Fadia M. Attia; Nader A. Ismail; Diana F. Mohamed. "Serum Level of P19 Subunit of Human Interleukin 23 in Psoriatic Patients Before & After Phototherapy of Ultra-Violet B (UVB) in Dermatology Outpatient Clinic Suez Canal University". Suez Canal University Medical Journal, 27, 5, 2024, 0-0. doi: 10.21608/scumj.2024.399067
Eiada, M., Attia, F., Ismail, N., Mohamed, D. (2024). 'Serum Level of P19 Subunit of Human Interleukin 23 in Psoriatic Patients Before & After Phototherapy of Ultra-Violet B (UVB) in Dermatology Outpatient Clinic Suez Canal University', Suez Canal University Medical Journal, 27(5), pp. 0-0. doi: 10.21608/scumj.2024.399067
Eiada, M., Attia, F., Ismail, N., Mohamed, D. Serum Level of P19 Subunit of Human Interleukin 23 in Psoriatic Patients Before & After Phototherapy of Ultra-Violet B (UVB) in Dermatology Outpatient Clinic Suez Canal University. Suez Canal University Medical Journal, 2024; 27(5): 0-0. doi: 10.21608/scumj.2024.399067

Serum Level of P19 Subunit of Human Interleukin 23 in Psoriatic Patients Before & After Phototherapy of Ultra-Violet B (UVB) in Dermatology Outpatient Clinic Suez Canal University

Article 7, Volume 27, Issue 5, May 2024, Page 0-0  XML
Document Type: Original Article
DOI: 10.21608/scumj.2024.399067
View on SCiNiTO View on SCiNiTO
Authors
Moustafa MK. Eiada1; Fadia M. Attia2; Nader A. Ismail1; Diana F. Mohamed* 3
1Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Suez Canal University
22Department of Clinical Pathology, Faculty of Medicine, Suez Canal University.
3Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Suez Canal University.
Abstract
Background:Psoriasis is a skin condition distinguished by inflammation, hyperproliferation of epidermal cells, & a noticeable influx of macrophages, neutrophils, & T lymphocytes. T-helper 1 (Th1) cells were once thought to be the mediating factor in psoriatic inflammation; however, more & more recent research suggests that immunological responses by recently identified Th17 cells have a role in the pathophysiology of psoriasis. Objective: To study the influence of UVB on the serum level of P19 subunit of IL-23 in patients with psoriasis. Patients and Methods: Every patient was chosen at random from the Suez Canal University Hospital's dermatology outpatient clinics. Before their involvement in this study, all patients provided their informed permission. The Suez Canal University Hospital's College of Medicine's Ethical Committee gave the study its approval. A thorough history taking & a general & dermatological clinical examination were performed on each patient. Blood samples were obtained at baseline & one-week post-treatment (week 12) to test P19 subunit of IL-23 level & perform a blind clinical assessment using PASI score calculation. Three factors are used to assess the severity of psoriasis: E stands for erythema; I for infiltration; & D for desquamation.Results:  In our study, 24(80%) of patients were male & 6(20%) patients were female. The mean ± SD of the age of patients is 33.27 ± 10.27 years (range 19-45). Most of the patients 21(70%) were smokers with BMI of (24.18 ± 3.08) ranging from 21 to 33 kg/m2. Regarding psoriasis area & severity, the PASI score was 14.33±4.24 ranging from 10 to 16. Also, 8(26.7%) of cases had positive family history & 15(50%) of patients had stationary courses, 3 (10%) had regressive courses & 12(40%) had progressive course. Half of patients 15(50%) had psoriasis at the head & upper limb, while 18(60%) had disease at trunk & 21(70%) had the disease at the lower limb. Patients had a mean duration of disease of 7.16 ± 2.34 years ranging from 2 to 20 years & mean age of disease onset of 34.74 ± 11.07 ranged from 19 to 45 years old. Conclusion: we found that, UVB treatment resulted in a reduction in P19 subunit of IL23 & also PASI score. Also, there were significant correlations between P19 subunit of IL23, the duration of the disease & PASI score.
Keywords
Ultra-Violet B; dendritic cells
Main Subjects
Clinical Research (Medical)
Statistics
Article View: 89
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.